Browsing Tag
Sandeep Rao
1 post
Solara Active Pharma’s Ambernath site clears third consecutive USFDA audit with Zero 483 observations
Solara’s Ambernath facility clears USFDA audit with zero 483s, boosting investor confidence despite financial caution. Read why institutions are watching closely.